What Analysts Think of Johnson & Johnson Stock Ahead of Earnings | Global News Avenue

Johnson & Johnson (Johnson & Johnson) will report earnings before the bell on Wednesday, and analysts expect revenue and profit to rise from a year ago.

Analysts are cautiously optimistic about the pharmaceutical and medical device maker, with six of the 12 analysts tracked by Visible Alpha giving it a “buy” rating and six giving it a “buy” rating “Hold” rating. their average price target About $175 represents a 19% gain from Friday’s closing price.

income and net income Sales in the fourth quarter of fiscal 2023 are expected to increase from $21.4 billion and $4.05 billion to $22.51 billion and $4.4 billion, respectively.

After a short surge Company third quarter The financial report shows that from mid-October to the end of 2024, Johnson & Johnson’s stock price trended downward, falling nearly 8% at the end of the year. The stock had risen nearly 2% so far in January to $147.03 as of Friday’s close.

Johnson & Johnson faces unresolved talc lawsuit and credit rating risk

The company faces a number of headwinds heading into the new year, including an expiring patent that creates competition for one of its most popular drugs and a class-action lawsuit alleging that its talc causes ovarian cancer remains unresolved. A hearing is scheduled for early this year to determine whether the company plans to have a subsidiary file for bankruptcy and multi-billion dollar settlement Packages will be allowed to move forward.

The biopharmaceutical company made multiple acquisitions in 2024 and started another in 2025 Acquires drug maker Intra-Cellular Therapies (Information Technology Industry Association) in a $14.6 billion deal, which is expected to close sometime this year.

Johnson & Johnson said it expects to finance the transaction through a combination of cash and debt. However, the potential for intracellular transactions and other future debt acquisitions has resulted in Standard & Poor’s Last week I talked about the company AAA credit rating may be in danger, Bloomberg report.